Table 3 Summary of HIV and HHV-8 screening among MNH patients by either IFA or ELISA between 1990 and 2001
| Â | Assay | IFA | ELISA | Â | ||
|---|---|---|---|---|---|---|
Disease group | Serostatus | HHV8+ | HHV8- | HHV8+ | HHV8- | Total |
KS | HIV+ | 42 (45.2) | 3 (3.2) | 46 (49.5) | 2 (2.2) | 93 (77.5) |
| Â | HIV- | 10 (37.0) | 2 (7.4) | 15 (55.6) | 0 | 27 (22.5) |
| Â | All cases | 52 (43.3) | 5 (4.2) | 61 (50.8) | 2 (1.7) | 120 (100.0) |
Non-KS tumors | HIV+ | 1 (100.0) | 0 | 0 | 0 | 1 (4.2) |
| Â | HIV- | 8 (34.8) | 1 (4.3) | 13 (56.5) | 1 (4.3) | 23 (95.8) |
| Â | All cases | 9 (37.5) | 1 (4.2) | 13 (54.2) | 1 (4.2) | 24 (100.0) |
Non-neoplastic | HIV+ | 11 (39.3) | 3 (10.7) | 14 (50.0) | 0 | 28 (70.0) |
| Â | HIV- | 0 | 10 (83.3) | 2 (16.7) | 0 | 12 (30.0) |
| Â | All cases | 11 (27.5) | 13 (32.5) | 16 (40.0) | 0 | 40 (100.0) |
| Â | Total | 72 (39.1) | 19 (10.3) | 90 (49.0) | 3 (1.6) | 184 (100.0) |